FTRE
Fortrea Holdings Inc.Healthcare · $1.9B market cap
Verdict
We can't put a fair value on FTRE right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.
Business quality
0 of 5 clear the 10% bar. What are the Big Five?
Follow FTRE
Track it on your watchlist and see the full analysis. Free.
Create a free accountInsider activity
Since Sep 8, 2026: no open-market purchases, 2 sales worth $57K and 2 other filings (stock awards, tax withholding and similar). Why purchases matter
Sales
Morais Mark A.
Chief Operating Officer · 2026-09-09
Sold
$53K
Russell Carrie Elizabeth
Interim CAO · 2026-09-09
Sold
$4K
Other filings
About Fortrea Holdings Inc.
Fortrea Holdings Inc. functions as a global contract research organization (CRO), concentrating on providing development services for biopharmaceutical products and medical devices. The company's operations are divided into two main segments: Clinical Services and Enabling Services. Its Clinical Services division offers support across the entire spectrum of clinical pharmacology and development. The Enabling…
Biotechnology
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works